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Nonmonotonic effectsThe periaqueductal gray (PAG) columns have been implicated in controlling stress responses through
corticotropin-releasing factor (CRF), which is a neuropeptide with a prominent role in the etiology of fear-
and anxiety-related psychopathologies. Several studies have investigated the involvement of dorsal PAG
(dPAG) CRF mechanisms in models of unconditioned fear. However, less is known about the role of this neu-
rotransmission in the expression of conditioned fear memories in the dPAG and ventrolateral PAG (vlPAG)
columns. We assessed the effects of ovine CRF (oCRF 0.25 and 1.0 μg/0.2 μL) locally administered into the
dPAG and vlPAG on behavioral (fear-potentiated startle and freezing) and autonomic (arterial pressure
and heart rate) responses in rats subjected to contextual fear conditioning. The lower dose injected into
the columns promoted proaversive effects, enhanced contextual freezing, increased the blood pressure and
heart rate and decreased tail temperature. The lower dose of oCRF into the vlPAG, but not into the dPAG, pro-
duced a pronounced enhancement of the fear-potentiated startle response. The results imply that the PAG is
a heterogeneous structure that is involved in the coordination of distinct behaviors and autonomic control,
suggest PAG involvement in the expression of contextual fear memory as well as implicate the CRF as an
important modulator of the neural substrates of fear in the PAG.
© 2013 Elsevier Inc. All rights reserved.Introduction
The neuropeptide corticotropin-releasing factor (CRF) has been
implicated in the regulation of the neuroendocrine reaction (Vale
et al., 1981). Over the last decades, CRF has been shown to modulate
the autonomic, immunologic, behavioral and cognitive responses to
aversive stimuli (Bale and Vale, 2004). CRF receptors (CRF1 and CRF2)
have been demonstrated to be broadly distributed in the structures that
compose the limbic circuitry (De Souza et al., 1985; Hauger et al., 2006;
Owens and Nemeroff, 1991; Swanson et al., 1983) and experimental
evidence demonstrated that intracerebroventricular (i.c.v.) CRF adminis-
tration increases anxiety-related behavior in rodents (Momose et al.,
1999; Yang et al., 2006). CRF speciﬁcally inﬂuences the reaction to aver-
sive stimuli when locally injected into structures such as the amygdala
(Hubbard et al., 2007; Pitts and Takahashi, 2011), hippocampus
(Pentkowski et al., 2009; Todorovic et al., 2007), bed nucleus of the
stria terminalis (Sink et al., 2012;Walker et al., 2009) and periaqueductal. Bandeirantes, 3900, 14040-901,
rights reserved.gray (PAG) (Borelli and Brandão, 2008; Carvalho-Netto et al., 2007;
Martins et al., 1997, 2000; Miguel and Nunes-de-Souza, 2011).
The PAG is a limbic structure that is considered to be a ﬁnal path-
way of the stress reaction (Brandão et al., 2005; Carrive, 1993). Ana-
tomical and histological analyses have divided this structure into
longitudinal columns parallel with the aqueduct, including the dorsal
(dPAG, comprising dorsomedial and dorsolateral columns), lateral (lPAG)
and ventrolateral (vlPAG) columns (Bandler and Shipley, 1994; Carrive,
1993; Keay and Bandler, 2001). In rodents, PAG electrical stimulation,
lesions or pharmacological manipulation alters anxiety-like behaviors in
several paradigms, such as open ﬁeld (Borelli et al., 2004; Brandão et al.,
1999; Coimbra et al., 2006), elevated plus-maze (Netto and Guimarães,
2004), conditioned-place aversion (Zanoveli et al., 2007), contextual
conditioned fear (Kim et al., 1993; Walker and Carrive, 2003) and
fear-potentiated startle (Reimer et al., 2012; Zhao et al., 2009).
Receptor autoradiography and binding studies in different central
nervous system regions in the rat demonstrated that there is a substan-
tial population of both CRF receptor subtypes within the different PAG
columns (Merchenthaler, 1984; Swanson et al., 1983). In support of a
CRF neurotransmitter role within the PAG columns, the CRF receptor lo-
calization correspondswellwith the distribution of CRF-immunoreactive
terminals in this structure (Steckler and Holsboer, 1999). Furthermore,
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dominantly in its ventral portion, medial to the Edinger–Westphal
nucleus and CRF ﬁbers can also be seen coursing from the amygdala,
bed nucleus of the stria terminalis and hypothalamus to the dPAG
(Gray and Magnuson, 1992; Swanson et al., 1983). Also, Bowers et al.
(2003) using an electrophysiological recording technique showed
that CRF produced a dose dependent excitatory effect on PAG neurons,
both in dorsal and in ventrolateral subdivisions.
Ovine CRF (oCRF) and cortagine, a selective CRF1 agonist, admin-
istered into dPAG produced anxiogenic-like effects in the mouse de-
fense test battery and rat exposure test, which are animal models
used to investigate mice defensive patterns in the presence of natural
aversive stimuli (Carvalho-Netto et al., 2007; Litvin et al., 2007).
Additionally, intra-dPAG injection of the CRF antagonist α-helical-CRF
reduced anxiety-related behaviors in rodents subjected to the elevated
plus-maze (Martins et al., 2000), whereas oCRF produced opposite
responses (Borelli and Brandão, 2008). Although a number of studies
has investigated the involvement of dPAG CRF mechanisms in models
of unconditioned fear (Borelli and Brandão, 2008; Carvalho-Netto et
al., 2007; Litvin et al., 2007; Miguel and Nunes-de-Souza, 2011), less
is known about the CRF neurotransmission in the expression of condi-
tioned fear memories in the PAG columns. To further investigate this
issue, we assessed the effects of CRF locally administered into the
dPAG and vlPAG on behavioral (fear-potentiated startle and freezing)
and autonomic (arterial pressure and heart rate) responses in rats
subjected to contextual fear conditioning. In this paradigm, electrical
footshocks are paired with an initially neutral background context.
After some pairings, the context evokes a conditioned fear reaction
consisting of behavioral and autonomic responses including freezing,
urination, increased arterial blood pressure and ultrasonic vocalization
(Antoniadis and McDonald, 1999; Bouton and Bolles, 1979; Fanselow




The experiments reported in this article were performed in accor-
dancewith the recommendations of the Brazilian Society ofNeuroscience
and Behavior and complied with the United States National Institutes of
Health Guide for Care and Use of Laboratory Animals. The procedures
were approved by the Committee for Animal Care and Use, University
of São Paulo (No. 125-2010 and 11.1.308.53.9). All efforts were made to
minimize animal suffering and reduce the number of rats used.
Animals and surgical procedures
A total of 110 male Wistar rats from the animal house of the
University of São Paulo Ribeirão Preto campus weighing 220–270 g
were used in the study. The rats were housed in groups of four animals
per cage with food and water available ad libitum in a temperature-
controlled room (23 ± 1 °C) under a 12 h/12 h light/dark cycle (lights
on at 07:00 AM) for 72 h.
Before the experimental sessions, the rats were anesthetized with
ketamine/xylazine (100/7.5 mg/kg, intraperitoneal; Agener União,
Embu-Guaçu, SP, Brazil) and ﬁxed in a stereotaxic apparatus (David
Kopf, Tujunga, CA, USA). The upper incisor bar was set 3.3 mm below
the interaural line so that the skull was horizontal between bregma and
lambda. After scalp anesthesia with 2% lidocaine, the skull was surgically
exposed and a stainless steel guide cannula (10 mm length, 0.6 mm
outer diameter, 0.4 mm inner diameter) was unilaterally implanted
into the dPAG using lambda as the reference (angle of 16°; coordinates:
anterior/posterior, 0 mm; medial/lateral, ±1.9 mm; dorsal/ventral:
−4.1 mm) or vlPAG (angle of 18°; coordinates: anterior/posterior,
−0.2 mm; medial/lateral, ±2.6 mm; dorsal/ventral: −3.3 mm)according to Paxinos and Watson (2005). The cannula was ﬁxed to
the skull with dental cement and two stainless steel screws. After
surgery, the guide cannula was sealed with a stainless steel wire to
prevent obstruction, and the rats received an intramuscular injection
of penicillin G benzathine (Pentabiotic, 600,000 IU, 0.2 mL; Fort
Dodge, Campinas, SP, Brazil) and a subcutaneous injection of the
anti-inﬂammatory and analgesic Banamine (ﬂunixin meglumine,
2.5 mg/kg [10 mg/mL, 0.2 mL]; Schering-Plough, São Paulo, SP, Brazil).
After surgery, the rats were returned to their home cages in groups of
four and were allowed to recover over a period of ﬁve days. To assess
autonomic responses, one day prior to the test day, rats were anesthe-
tized with ketamine/xylazine, and a catheter (4 cm PE-10 segment
heat-bound to a 13 cm PE-50 segment; Clay Adams, Northridge, CA,
USA)was inserted into the abdominal aorta through the femoral artery
for cardiovascular recording. The catheterwas tunneled under the skin,
and exteriorized on the animal's dorsum.
Drug and infusion procedure
Ovine CRF (Sigma-Aldrich) was dissolved in 0.9% physiological
saline shortly before use to achieve a ﬁnal concentration of 0.25 μg
or 1 μg/0.2 μL. Physiological saline served as the vehicle control. The
drug was administered locally 5 min prior to testing. The doses and
times of the injections were based on previous studies (Borelli and
Brandão, 2008; Carvalho-Netto et al., 2007). Infusions were delivered
using an infusion pump (Harvard Apparatus, Holliston, MA, USA) in a
constant volume of 0.2 μL over 30 s. A thin dental needle (0.3 mm
outer diameter) attached by polyethylene tubing to a 5 μL Hamilton
syringe was introduced through each guide cannula. The injection
needle extended 1.0 mm (dPAG) or 3.0 mm (vlPAG) below the ven-
tral tip of the implanted guide cannula. The displacement of an air
bubble inside the polyethylene tubing that connected the syringe to
the injection needle was used to monitor the microinjections. The in-
jection needles were left in place for 30 s after the end of the infusion
to allow for diffusion.
Fear-potentiated startle test
The acoustic startle reﬂex is elicited by sudden, unexpected and
intense auditory stimulation, and involves a series of rapid and phasic
contractions of most of the skeletal muscles throughout the body. The
rapidity of the primary response suggests that a relatively simple
circuit mediates the startle reﬂex with few synapses interposed be-
tween the auditory nerve and the spinal motoneurons (Koch, 1999;
Yeomans et al., 2002). The fear-potentiated startle paradigmhas proven
to be useful for analyzing neural systems involved in fear and anxiety.
This test measures conditioned fear by an increase in the amplitude of
the acoustic startle reﬂex in the presence of an explicit or contextual
cue previously paired with a footshock (Davis et al., 1993; Grillon and
Baas, 2003).
Fifty-eight rats were tested to examine the involvement of the
PAG CRF mechanisms in the fear-potentiated startle response in a
context previously paired with footshocks. Ovine CRF was injected
into the dPAG or vlPAG before the test sessions. The choice of these
columns was based on previous data from our laboratory showing
that CRF mechanisms in the lPAG did not appear to be involved in the
expression of conditioned fear responses (Borelli et al., unpublished
data).
A wire-grid cage (16.5 × 7.5 × 7.5 cm) ﬁxed to a response platform
by four thumb screws was used as the test cage. The ﬂoor consisted
of six stainless steel bars 3.0 mm in diameter spaced 1.5 cm apart. The
cage and response platform were located inside a ventilated, sound-
attenuating plywood chamber (64 × 60 × 40 cm). A loudspeaker lo-
cated 10 cm behind the test cage delivered both the startle stimulus
(100 dB, 50 ms burst of white noise) and continuous background
noise (55 dB). The startle reaction of the rats generated pressure on
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analyzed using the Startle Reﬂex software (Med Associates, St. Albans,
VT, USA). The startle reaction was recorded within a time window of
100 ms after the onset of the startle stimulus. Calibration procedures
were conducted before the experiments to ensure equivalent sensitiv-
ities of the response platform.
Matching
For the ﬁrst 2 days, the rats were placed in the test cage for a
5 min habituation period. Afterwards, the rats received a total of 30
startle stimuli with an interstimulus interval of 30 s. Each matching
session lasted 20 min. The rats were assigned to different control and
drug groups to achieve similar average startle amplitudes among the
groups based on the last matching day. The mean startle amplitude
was deﬁned as the baseline condition before training began.
Training
Five days after surgery, the rats were conditioned to the back-
ground context in the previously described experimental cage. The
rats were placed individually in the cage and received 10 footshocks
(0.3 mA, 1 s), after a 5 min acclimation period, with a variable intertrial
interval of 60–180 s (Borelli et al., 2005; Reimer et al., 2008). The
footshocks were delivered through the training cage ﬂoor by a constant
current generator built with a scrambler (Albarsh Instruments; Porto
Alegre, RS, Brazil). Stimulus presentation was controlled by amicropro-
cessor and an I/O board (Insight Equipment; Ribeirão Preto, SP, Brazil).
Each animal was removed 5 min after the last shock and was returned
to its home cage. The duration of each training session was approxi-
mately 25 min.
Test
The test sessions were conducted without footshock presentation
in the same cage used for matching and training. Twenty-four hours
after training, the rats received intra-dPAG or vlPAG injection of
oCRF or saline and were placed in the startle test cage after 5 min.
After 5 min of habituation, the rats received 30 startle stimuli (noise
bursts) with a 30 s interstimulus interval. All the experimental steps
were performed in the morning between 8:00 AM and 11:00 AM.
Contextual fear conditioning test
Considerable evidence has shown that rodents acquire fear by ex-
posure to a distinctive environment in which aversive unconditioned
stimuli, such as a footshock, had previously been administered. In this
situation, the most prominent behavioral outcome is the freezing
response (Blanchard and Blanchard, 1969; Kim and Fanselow, 1992;
Phillips and LeDoux, 1992; Rudy, 1993).
Thirty-four rats were used to assess the involvement of CRF-related
mechanisms in the PAG in the expression of contextual freezing and
autonomic responses. Conditioning and test sessions were conducted in
the same chamber (25 × 22 × 22 cm). The side and backwalls consisted
of gray acrylic and the ceiling and front door consisted of transparent
Plexiglas. The grid consisted of 18 stainless steel rods spaced 1.5 cm
apart to deliver computer-controlled footshocks (Insight Instruments).
The chamber was cleaned with 20% alcohol after each session.
Training
Rats were individually placed in the chamber and received 3
footshocks (0.8 mA, 2 s) after a 3 min acclimation period. The intertrial
interval varied randomly between 20 and 60 s (Lisboa et al., 2010). The
rats were removed 3 min after the last shock and were returned to the
home cage.
Test
Rats were transferred from the animal room to the test room
(distinct from the conditioning room) in their home cage and remainedundisturbed for 1 h. Following this adaptation period, the arterial
cannula was connected to a pressure transducer, and baseline values
of cardiovascular parameters were recorded over 5 min (baseline 1).
After injection into the dPAG or vlPAG, autonomic measures were
recorded for 5 minwhile the rats remained in their home cage (baseline
2). The rats were replaced in the footshock chamber, and freezing be-
havior and autonomic responses were recorded for 10 min. The time
of the freezing response was used as the criterion to assess fear condi-
tioning. Freezing was operationally deﬁned as the total absence of
movement with the exception of respiration (Bouton and Bolles,
1979). All of the experiments weremonitored in real time by a trained
investigator who was unaware of the treatment condition and manu-
ally scored the freezing response. The mean arterial pressure (MAP)
and heart rate (HR) were recorded using an AECAD 04P ampliﬁer
(Solução Integrada Ltda.; São Carlos, SP, Brazil) and an acquisition
board (Power lab 8/30; ADInstruments, Colorado Springs, CO, USA)
connected to a personal computer. The MAP and HR values were de-
rived from pulse and arterial pressure recordings and were processed
online. The cutaneous temperature of the tail was recorded each min
using a thermal camera (Multi-Purpose Thermal Imager IRI 4010;
Infrared Integrated Systems Ltd., Northampton, UK) at a distance of
50 cm above the tail. The testing was conducted in a roommaintained
at 26 ± 1 °C, which is the thermoneutral zone for rats (Gordon, 1990).
For statistical purposes, the continuous recordingswere averaged over
60-s intervals. Changes in the MAP, HR or cutaneous temperature
(ΔMAP, ΔHR and ΔTemperature, respectively) were sampled at
1 min intervals. Points sampled during the 5 min period before the
exposure were used as control baseline values.
Histology
After the tests, the rats were deeply anesthetized with a lethal
dose of chloral hydrate (500 mg/kg, i.p.) and transcardially perfused
with 0.9% saline followed by 10% formalin. The brains were removed
from the skulls,maintained in formalin solution for 2 h and cryoprotected
in 30% sucrose for 72 h. Serial 60 μmbrain coronal sectionswere cut using
a cryostat (−19 °C), mounted on gelatin-coated slides and stained with
cresyl violet (5%, Sigma-Aldrich) to localize the microinjection sites by
microscopic examination according to the atlas of Paxinos and Watson
(2005). Eighteen rats were excluded from the analysis because of inap-
propriate cannula placement.
Statistical analysis
The software used for all statistical analyses was STATISTICA
version 6.0. The data are expressed as mean ± standard error of the
mean (s.e.m.). Two-way analysis of variance (ANOVA) with repeated
measures was used to assess the effects of oCRF injections into the
dPAG or vlPAG on the startle amplitude with treatments (drug and
saline) and conditions (baseline and test) as factors. Time of freezing
was analyzed using one-way ANOVA. Signiﬁcant comparisons were
further evaluated using the Newman–Keuls post-hoc test. The base-
line values of the MAP, HR and cutaneous temperature recorded
before chamber reexposure were compared using one-way ANOVA.
The MAP, HR and cutaneous temperature measured during the test
were analyzed using two-way ANOVA with treatment as the main in-
dependent factor and time as the repeated measurement. Post-hoc
comparisonswere performedwith t-tests and a Bonferroni adjustment.
In all cases, values of p b 0.05 were considered statistically signiﬁcant.
Results
Representative photomicrographs of microinjections into the dPAG
and vlPAG and diagrammatic representations of the saline and oCRF
injection sites in these areas are shown in Fig. 1.
Fig. 1. Photomicrographs showing representative sites of injections into the dorsal periaqueductal gray (A) and ventrolateral periaqueductal gray (C). Outline of the injection sites
in the dPAG and vlPAG (B and D, respectively) on cross-sections from the Paxinos and Watson atlas (2005). The number of points in the ﬁgure is less than the total number of rats
used because of several overlaps. Scale bar = 500 μm.
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A timeline of the procedures for testing the involvement of CRF
mechanisms in the expression of the fear-potentiated startle is depicted
in Fig. 2 (A). The mean startle amplitude for rats receiving intra-dPAG
saline (n = 10), oCRF 0.25 μg (n = 9), or oCRF 1.0 μg (n = 9) before
the testing session is shown in Fig. 2 (B). Two-wayANOVA revealed sta-
tistically signiﬁcant effects of the conditions (F1,25 = 33.76, p b 0.01)
but not of the treatments (F2,25 = 0.39, p > 0.05) or the treatments
vs. conditions interaction (F2,25 = 0.93, p > 0.05). The Newman–
Keuls post-hoc test revealed that reexposure to the environment in
which footshocks were previously administered enhanced the startle
response in all the groups. The mean startle amplitude for the rats
receiving intra-vlPAG saline (n = 11), oCRF 0.25 μg (n = 10), or
oCRF 1.0 μg (n = 9) before the testing session is illustrated in Fig. 2
(C). Two-wayANOVA revealed statistically signiﬁcant effects of the con-
ditions (F1,27 = 47.78, p b 0.05), treatments (F2,27 = 3.18, p b 0.05)
and the treatments vs. conditions interaction (F2,27 = 5.01, p b 0.05).The Newman–Keuls post-hoc test revealed that reexposure to the envi-
ronment in which footshocks were previously administered enhanced
the startle response in all the groups. However, the conditioned startle
reﬂex was higher in the group treated with oCRF 0.25 μg compared
with the control group.
Effect of intra-PAG CRF on the contextual fear conditioning test
A timeline of the procedure for testing the effects of the oCRF in-
jection into the PAG columns in the expression of contextual freezing
behavior and autonomic responses is depicted in Fig. 3 (A). The mean
freezing time exhibited for rats receiving intra-dPAG saline (n = 6),
oCRF 0.25 μg, or oCRF 1.0 μg (n = 5 each dose) before exposure to
the environment in which footshocks were previously administered
is illustrated in Fig. 3 (B). One-way ANOVA showed that the treat-
ment produced statistically signiﬁcant effect (F2,15 = 14.99, p b 0.01).
Post-hoc tests revealed that oCRF 0.25 μg increased the expression of
conditioned contextual freezing compared with the saline-treated rats.
Fig. 2. Timeline of the procedures for testing the effects of oCRF injection into the PAG columns on the expression of contextual fear (A). Effects of dPAG (B) or vlPAG (C) injections
of saline or oCRF (0.25 μg/0.2 μL and 1.0 μg/0.2 μL, respectively) on the mean startle amplitude response shown by rats submitted to contextual fear conditioning. Results are
expressed as means + s.e.m. #p ≤ 0.05 compared with the saline group and *p ≤ 0.05 compared with baseline (Newman–Keuls test).
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oCRF 0.25 μg, or oCRF 1.0 μg (n = 6 in each group) before exposure to
the environment in which footshocks were previously administered
is shown in Fig. 3 (C). One-way ANOVA revealed that the treatment pro-
duced statistically signiﬁcant effect (F2,17 = 144.90, p b 0.01). The
post-hoc test showed that oCRF 0.25 μg increased the expression of con-
ditioned contextual freezing compared with the control group.Effect of intra-PAG CRF on autonomic measures
The autonomic responses evaluated in this study are depicted
in Figs. 3 (D–I). Ovine CRF injection into the dPAG or vlPAG did not
affect the baseline values of MAP, HR or the cutaneous temperature
(data not shown). Reexposure to the environment inwhich footshocks
were previously administered induced a sustained increase in the
cardiovascular responses (dPAG-MAP: F14,195 = 12.92, p b 0.001
and HR: F14,195 = 66.57, p b 0.001; vlPAG-MAP: F14,225 = 68.68,
p b 0.001 and HR: F14,225 = 128.40, p b 0.001) and decreased tail
temperature during the test (dPAG—F14,195 = 73.91, p b 0.001 and
vlPAG—F14,225 = 79.96, p b 0.001). There was a signiﬁcant increase
in the autonomic responses evoked by chamber reexposure after
the treatment with oCRF 0.25 μg in the dPAG (MAP: F2,195 = 25.99,
p b 0.001; HR: F2,195 = 87.41, p b 0.001 and tail temperature:
F2,195 = 73.56, p b 0.001). A signiﬁcant interactionwas also observed
between treatment and time (MAP: F28,195 = 2.92, p b 0.001; HR:
F28,195 = 3.52, p b 0.001 and tail temperature: F28,195 = 3.14,
p b 0.001). Similar resultswere observedwhenoCRFwas administered
into the vlPAG: injections of low doses of oCRF increased the autonomic
responses during reexposure to the conditioning chamber (MAP:
F2,225 = 208.60, p b 0.001; HR: F2,225 = 112.40, p b 0.001 and tail
temperature: F2,225 = 78.36, p b 0.001). A signiﬁcant interaction
was also observed between treatment and time (MAP: F28,225 =
8.62, p b 0.001; HR: F28,225 = 4.19, p b 0.001 and tail temperature:
F28,225 = 3.68, p b 0.001). Treatment of ovine CRF 1 μg in the dPAG
or vlPAG did not change the autonomic responses during reexposure
to the aversive contextDiscussion
To assess the involvement of intra-PAG CRFergic mechanisms in
the behavioral (fear-potentiated startle and freezing) and autonomic
(MAP, HR and tail temperature) expression of fear conditioning, oCRF
was injected into the dPAG and vlPAG of rats before exposure to an
environment in which footshocks were previously administered.
Although intra-dPAG oCRF did not alter the startle response exhibited
by rats exposed to contextual fear, the lower dose promoted a
proaversive effect, which enhanced contextual freezing, blood pres-
sure and heart rate and decreased the tail temperature. These ﬁndings
are consistent with previous studies demonstrating that intra-dPAG
oCRF increased unconditioned anxiety-like responses in the EPM
(Borelli and Brandão, 2008) and intra-dPAG administration of the
CRF antagonist α-helical-CRF reduced anxiety-related behaviors in
stress-experienced rats (Martins et al., 2000).
The increased contextual freezing and autonomic responses
caused by the lower dose of the drug indicate that the lack of effect
on fear-potentiated startle was not an artifact of improper dosage.
Moreover, the role of CRF mechanisms in the startle response is not
clear (de Jongh et al., 2003; Schulz et al., 1996; Swerdlow et al.,
1989) and appears to depend on a number of factors, including the
stimulated region (Bijlsma et al., 2011; Walker et al., 2009; Zhao et
al., 2009), functional integrity of brain structures (Antoniadis et al.,
2009; Fendt et al., 1994; Lee and Davis, 1997), participation and inter-
action with other neurochemical systems (Boyson et al., 2011; Conti,
2012; Gresack and Risbrough, 2011) and involvement of distinct CRF
receptors (Risbrough et al., 2003, 2004, 2009). Based on the distinct
effects of oCRF injection into the dPAG on conditioned freezing and
fear-potentiated startle, different neurochemicalmechanisms andneu-
ral circuitries could mediate the fear responses generated in these two
tests (Borelli et al., 2005; de Oliveira et al., 2012; Reimer et al., 2012).
The dorsal regions of the PAG may be involved in the expression of
unconditioned and/or avoidance behaviors, whereas conditioned re-
sponses may recruit the ventral parts of this mesencephalic structure.
We previously demonstrated that intra-dmPAG injection of oCRF in-
creased risk assessment behaviors in rats subjected to the EPM test
Fig. 3. Timeline of the procedures for testing the effects of the oCRF injection into the PAG columns in the expression of contextual freezing behavior and autonomic responses (A).
Percentage of freezing time response in rats receiving intra-dPAG (B) or vlPAG (C) injection of 0.2 μL of saline, oCRF 0.25 μg, or oCRF 1.0 μg/0.2 μL subjected to contextual fear.
Time-course of microinjection of saline or oCRF at doses of 0.25 μg or 1.0 μg/0.2 μL into the dPAG (left column) or vlPAG (right column) on mean arterial pressure (MAP; D and E),
heart rate (HR; F and G) and cutaneous temperature (H and I) of rats exposure to the environment in which footshocks were previously administered. Results are expressed as
means ± s.e.m. *p ≤ 0.05 compared with the control group.
796 K.G. Borelli et al. / Hormones and Behavior 63 (2013) 791–799(Borelli and Brandão, 2008). This class of behavior has been proposed
to reﬂect information-gathering processes triggered in potentially
threatening situations, which optimizes the best adaptive behavioral
strategy (Albrechet-Souza et al., 2009; Blanchard et al., 1993).
In contrast to the dPAG, rats that received intra-vlPAG injections of
oCRF at the lower dose before the test session exhibited increasedfear-potentiation startle. The same dose also increased the contextual
freezing response, blood pressure and heart rate and decreased the
tail temperature,which indicates proaversive effects of CRF in emotional
circuitry areas (Griebel, 1999; Owens and Nemeroff, 1991; Yang et al.,
2006). These results suggest that endogenous CRF systems in the PAG
columns may have a role in modulating behavioral and autonomic
797K.G. Borelli et al. / Hormones and Behavior 63 (2013) 791–799responses to stress. The results also support the speciﬁcity of PAG co-
lumnar modulation of aversive responses once CRF seems to present
a distinct action in the dPAG and vlPAG. Thus, different neural circuits
could be recruited at the PAG level during the expression of the contex-
tual freezing and the production of fear-potentiated startle mediated
by the CRF system.
Our ﬁndings show that, compared with dPAG, vlPAG CRF-related
mechanisms are involved on the expression of distinct conditioned fear
responses. CRF immunoreactive terminals in the PAG originate from
the amygdala, bed nucleus of the stria terminalis and hypothalamus
(Gray and Magnuson, 1992). High-density CRF-immunoreactive neu-
rons are located in the amygdaloid complex and the basolateral nucleus
of the amygdala is well-established to be involved with the CS–US asso-
ciation (Pitts and Takahashi, 2011). Thus, fear expression appears to orig-
inate from basolateral nucleus projections crossing through the central
nucleus of the amygdala to the bed nucleus of the stria terminalis
(Dong et al., 2001) and projecting into the vlPAG (Dong and Swanson,
2004), which is directly involved in the expression of the conditioned
fear responses (LeDoux et al., 1988; Walker and Carrive, 2003).
Considering the effects of oCRF on autonomic measurements our
results indicated that activation of CRF receptors in the PAG columns
(dPAG and vlPAG) are involved in themediation of autonomic response
to stress. In fact, the PAG contains the neural substrate required to re-
cruit the sympathetic nervous system and organizes physiological and
behavioral responses required to respond to environmental challenges
(Dean, 2011; Lovick, 1985). A prior study showed that CRF i.c.v. admin-
istration elicits cardiovascular responses similar to the effects of stress
by increasing heart rate, cardiac output and mean arterial pressure,
responses mediated by an intact sympathetic nervous system (Fisher
et al., 1983). Morimoto et al. (1993) clearly demonstrated that during
stress responses, central CRF modulates anxiety-related cardiovascular
responses, altered body temperature and altered locomotor activity.
These responses were signiﬁcantly attenuated by pretreatment with i.c.v.
injection of the CRF antagonist a-helical CRF (9–41), although signiﬁcant
changes were not induced in unstressed rats. Interestingly, oCRF injected
into the dPAG and vlPAGdid not alter autonomicmeasurements in rats be-
fore exposure to the aversive context, indicating the speciﬁc involvementof
this peptide in modulating the responses elicited by the PAG during the
stress response. Thus, it is likely that CRF mechanisms in the PAG do not
mediate cardiovascular responses and body temperature regulation dur-
ing the resting state in a nonstressful environment.
In this study, however, oCRF injected into the dPAG or vlPAG at
higher doses did not induce behavioral or autonomic changes, and
some possibilities can be considered to explain these results. A reason-
able possibility could be that oCRF, at higher doses, may nonspeciﬁcally
act on both CRF1 and CRF2 receptors, clearly supporting the notion of
opposed information processing mechanisms of these receptors during
the stress (Bakshi and Kalin, 2000; Koob and Heinrichs, 1999; Reul and
Holsboer, 2002). Indeed, some evidence indicates that anxiety-like be-
haviors mediated by CRF1 activation are reduced when CRF2 receptors
are activated (Bale et al., 2000; Kishimoto et al., 2000). Alternatively,
this absence of effects may be associated to an “inverted U” dose–
response mechanism, often observed for a wide variety of neuropep-
tides (McGaugh, 1983; Price and Cooper, 1975). These phenomena
encompass every level of biological organization from gene expression,
hormone production and cell number to changes in tissue architecture
(for review see Vandenberg et al., 2012).
Altogether, our ﬁndings corroborate the previous idea of the PAG
as a heterogeneous structure involved in the coordination of distinct
behaviors and autonomic control (Borelli et al., 2005; Rea et al., 2011;
Vieira et al., 2011) and further indicate the participation of PAG CRF
mechanisms in stress responses exhibited in threatening environments.
Indeed, some anxiety disorders have been linked to abnormalities in
CRF signaling. Patients with post-traumatic stress disorder exhibit ele-
vated levels of CRF in the cerebrospinal ﬂuid (de Kloet et al., 2008;
Sautter et al., 2003). Mutations in CRF (Smoller et al., 2005) and theCRF1 receptor genes (Keck et al., 2008) have been associatedwith traits
predictive for panic disorder and panic disorder diagnoses, respectively.
Thus, identifying CRF receptor signaling pathways that mediate defen-
sive responses is crucial to extend our understanding of the neural
basis of physiological fear, as well as associated disorders.Acknowledgments
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